Skip to main content
. 2022 Jan 20;14:83–93. doi: 10.2147/CLEP.S341048

Table 1.

Characteristics and Bivariate Odds Ratios in Venous Thromboembolism (VTE) Cases and Matched Controls: Asthma Patients Aged 20–59 Years in CPRD GOLD 1995–2015

Cases (n=1168) Controls (n=4672) OR 95% CI
Age at Index Date (years)
20–29 86 (7.4) 344 (7.4) NAa NAa
30–39 207 (17.7) 828 (17.7) NAa NAa
40–49 284 (24.3) 1136 (24.3) NAa NAa
50–59 591 (50.6) 2364 (50.6) NAa NAa
Sex
Male 483 (41.4%) 1932 (41.4%) NAa NAa
Female 685 (58.7%) 2740 (58.7%) NAa NAa
BMI (kg/m2)
<18 11 (0.9%) 48 (1.0%) 1.4 0.7–2.8
18–24 241 (20.6%) 1526 (32.7%) 1.0 (reference) 1.0 (reference)
25–30 289 (24.7%) 1357 (29.1%) 1.4 1.1–1.7
>30 532 (45.6%) 1284 (27.5%) 2.7 2.3–3.2
Unknown 95 (8.1%) 457 (9.8%) 1.3 1.0–1.7
Smoking Status
Non-smoker 490 (42.0%) 2219 (47.5) 1.0 (reference) 1.0 (reference)
Current smoker 286 (24.5%) 989 (21.2) 1.3 1.1–1.5
Past-smoker 361 (30.9%) 1342 (28.7) 1.2 1.0–1.4
Unknown 31 (2.7%) 122 (2.6) 1.1 0.7–1.8
Comorbidities
Phlebitis 101 (8.7%) 66 (1.4) 6.8 4.9–9.4
Hypertension 196 (16.8%) 842 (18.0) 0.9 0.8–1.1
Diabetes 69 (5.9%) 189 (4.1) 1.5 1.1–2.0
Hyperlipidemia 96 (8.2%) 495 (10.6%) 0.7 0.6–0.9
Alcohol abuse 14 (1.2%) 48 (1.0%) 1.2 0.6–2.1
COPD 114 (9.8%) 327 (7.0%) 1.5 1.2–1.9
Epilepsy 6 (0.5%) 15 (0.3%) 1.6 0.6–4.1
Other Proximate Causes of VTE within 90 Days
HRT or OC useb 123 (10.5%) 382 (8.2%) 1.4 1.1–1.7

Notes: aMatching factor; bAmong women only.

Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval; NA, not applicable; HRT, hormone replacement therapy; OC, oral contraceptive.